Company / R&D per Share
C4 Therapeutics, Inc. R&D per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.48
FY2025
5-year range
$1.48 / $2.40
FY2022-FY2025
Trend
-24.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2.40 to $1.48 over the past 2 years.
Based on SEC 10-K filings.
1.48 in FY2025 with a 3-year CAGR of -8.8%.
Declined from $2.40 to $1.48 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -8.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 24.2% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.48 | -24.2% |
| FY2024 | $1.95 | -19.0% |
| FY2023 | $2.40 | +23.6% |
| FY2022 | $1.94 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026